×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
APYX – apyx medical corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
APYX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/29
08:00 am
apyx
Apyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Low
Report
Apyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
1/22
06:43 am
apyx
How Evolving Valuation Views Are Rewriting The Story For Apyx Medical (APYX) [Yahoo! Finance]
Medium
Report
How Evolving Valuation Views Are Rewriting The Story For Apyx Medical (APYX) [Yahoo! Finance]
1/12
08:27 am
apyx
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results [Yahoo! Finance]
Medium
Report
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results [Yahoo! Finance]
1/12
08:00 am
apyx
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results
High
Report
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results
1/7
09:33 am
apyx
How The AYON Story Is Reshaping The Apyx Medical (APYX) Investment Case [Yahoo! Finance]
Low
Report
How The AYON Story Is Reshaping The Apyx Medical (APYX) Investment Case [Yahoo! Finance]
12/24
12:26 am
apyx
What The AYON Launch Means For Apyx Medical's Evolving Story And Valuation [Yahoo! Finance]
Neutral
Report
What The AYON Launch Means For Apyx Medical's Evolving Story And Valuation [Yahoo! Finance]
12/19
05:57 am
apyx
Apyx Medical (NASDAQ:APYX) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
Apyx Medical (NASDAQ:APYX) was upgraded by analysts at Zacks Research to a "hold" rating.
12/17
07:24 am
apyx
Apyx Medical (NASDAQ:APYX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Low
Report
Apyx Medical (NASDAQ:APYX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/29
05:21 pm
apyx
Form 4 Apyx Medical Corp For: Jan 27 Filed by: Roman Shawn David
Low
Report
Form 4 Apyx Medical Corp For: Jan 27 Filed by: Roman Shawn David
1/20
10:03 am
apyx
Form SCHEDULE 13G/A Apyx Medical Corp Filed by: ROYCE & ASSOCIATES LP
Low
Report
Form SCHEDULE 13G/A Apyx Medical Corp Filed by: ROYCE & ASSOCIATES LP
1/12
08:03 am
apyx
Form 8-K Apyx Medical Corp For: Jan 12
High
Report
Form 8-K Apyx Medical Corp For: Jan 12
12/12
04:06 pm
apyx
Form 8-K Apyx Medical Corp For: Dec 08
Low
Report
Form 8-K Apyx Medical Corp For: Dec 08
11/19
04:31 pm
apyx
Form 8-K Apyx Medical Corp For: Nov 17
Low
Report
Form 8-K Apyx Medical Corp For: Nov 17
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/7
Form 10-Q Apyx Medical Corp For: Jun 30
15.2%
11/11 Apyx Medical Corporation Reports Third Quarter of 2019 Financial Results and Updates Fiscal Year 2019 Outlook 14.3%
3/17 Apyx Medical Corp (NASDAQ: APYX) had its price target lowered by analysts at Piper Sandler from to . 11.7%
12/3 Form 8-K Apyx Medical Corp For: Dec 03 8.3%
5/4 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm Before June 17 8.1%
5/8 Q1/2019 3/31/2019 EPS -0.140 ZacksConsensus -0.190 ActVsEst 0.050 - Beat 8.0%
3/25 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX 7.6%
3/23 APYX MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corporation on Behalf of Stockholders and Encourages Investors to Contact the Firm 6.8%
8/10 Apyx Medical Corp (APYX) CEO Charlie Goodwin on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.7%
7/1 Apyx Medical Corporation Joins Russell 3000® and Russell 2000® Indexes 3.4%
11/11 Apyx Medical Corporation Reports Third Quarter of 2019 Financial Results and Updates Fiscal Year 2019 Outlook 14.3%
3/17 Apyx Medical Corp (NASDAQ: APYX) had its price target lowered by analysts at Piper Sandler from to . 11.7%
12/3 Form 8-K Apyx Medical Corp For: Dec 03 8.3%
5/4 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm Before June 17 8.1%
5/8 Q1/2019 3/31/2019 EPS -0.140 ZacksConsensus -0.190 ActVsEst 0.050 - Beat 8.0%
3/25 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX 7.6%
3/23 APYX MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Apyx Medical Corporation on Behalf of Stockholders and Encourages Investors to Contact the Firm 6.8%
8/10 Apyx Medical Corp (APYX) CEO Charlie Goodwin on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.7%
7/1 Apyx Medical Corporation Joins Russell 3000® and Russell 2000® Indexes 3.4%
TOP News Decliners
3/13
APYX MEDICAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Apyx Medical Corporation - APYX
-17.1%
3/19 INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Apyx Medical Corporation and Encourages Investors with Losses to Contact the Firm -9.9%
8/5 Apyx Medical Corporation Receives 510(k) Clearance for Next-Generation J-Plasma® Precise Handpiece Designed for Laparoscopic Surgery -9.9%
4/12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX -9.6%
3/20 ROSEN, A LEADING LAW FIRM, Announces Investigation of Securities Claims Against Apyx Medical Corporation – APYX -8.1%
11/29 Global Intraoperative Neuromonitoring Market Outlook 2018 & 2019-2027 -6.8%
3/17 Equity Alert: Rosen, a Globally Recognized Firm, Announces Investigation of Securities Claims Against Apyx Medical Corporation – APYX -6.4%
8/22 Apyx Medical Corporation to Participate in Upcoming Investor Conferences in September and October -5.9%
11/14 Apyx Medical Corp (NASDAQ: APYX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.75 price target on the stock. -5.9%
3/5 Form 4 Apyx Medical Corp For: Jan 10 Filed by: Swandal Craig A. -5.7%
3/19 INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Apyx Medical Corporation and Encourages Investors with Losses to Contact the Firm -9.9%
8/5 Apyx Medical Corporation Receives 510(k) Clearance for Next-Generation J-Plasma® Precise Handpiece Designed for Laparoscopic Surgery -9.9%
4/12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical Corporation - APYX -9.6%
3/20 ROSEN, A LEADING LAW FIRM, Announces Investigation of Securities Claims Against Apyx Medical Corporation – APYX -8.1%
11/29 Global Intraoperative Neuromonitoring Market Outlook 2018 & 2019-2027 -6.8%
3/17 Equity Alert: Rosen, a Globally Recognized Firm, Announces Investigation of Securities Claims Against Apyx Medical Corporation – APYX -6.4%
8/22 Apyx Medical Corporation to Participate in Upcoming Investor Conferences in September and October -5.9%
11/14 Apyx Medical Corp (NASDAQ: APYX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.75 price target on the stock. -5.9%
3/5 Form 4 Apyx Medical Corp For: Jan 10 Filed by: Swandal Craig A. -5.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: